Section Arrow
ABSI.NASDAQ
- Absci Corp
Quotes are at least 15-min delayed:2026/08/09 00:02 EDT
Regular Hours
Last
 8.93
+0.63 (+7.59%)
Day High 
8.97 
Prev. Close
8.3 
1-M High
12 
Volume 
2.19M 
Bid
8.93
Ask
8.99
Day Low
8.47 
Open
8.55 
1-M Low
6.692 
Market Cap 
1.41B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.77 
20-SMA 8.39 
50-SMA 8.37 
52-W High 12.055 
52-W Low 2.24 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.82/-0.11
Enterprise Value
1.41B
Balance Sheet
Book Value Per Share
1.02
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.80M
Operating Revenue Per Share
0.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VIVSVivoSim Lab Inc0.468+0.1381+41.86%0.47PE
CELZCreative Medical Technology Holdings1.42+0.27+23.48%-- 
IOVAIovance Biotherapeutics6.34+0.13+2.09%-- 
ARDXArdelyx4-0.87-17.86%-- 
ENSCEnsysce Biosciences0.5202-0.0041-0.78%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cellline development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.